Dental Bone Graft Substitutes Market Size, Share, Growth and Forecast by 2034

According to Fortune Business Insights, the global dental bone graft substitutes market size was valued at USD 328.14 million in 2025 and is projected to grow from USD 350.25 million in 2026 to USD 612.03 million by 2034, exhibiting a CAGR of 7.23% during the forecast period.

The global Dental Bone Graft Substitutes Market is witnessing steady growth, driven by the rising prevalence of dental disorders, increasing adoption of dental implants, and continuous advancements in regenerative biomaterials. The market is expanding due to growing awareness of oral healthcare and the need for effective bone regeneration solutions in dentistry.

Market Overview

Dental bone graft substitutes are widely used in procedures such as dental implants, ridge augmentation, sinus lifts, and periodontal defect repair. These materials help regenerate bone structure and ensure successful implantation outcomes. The increasing incidence of tooth loss, periodontal diseases, and maxillofacial injuries is significantly boosting the demand for these substitutes.

Additionally, technological advancements in biomaterials—such as synthetic grafts and demineralized bone matrix—are improving clinical outcomes and accelerating market adoption. The growing geriatric population, which is more prone to dental disorders, further contributes to market expansion.

Information Source: https://www.fortunebusinessinsights.com/dental-bone-graft-substitutes-market-110351 

Market Drivers

One of the primary drivers of the market is the rising number of dental implant procedures worldwide. As dental implants become a preferred solution for tooth replacement, the demand for bone graft substitutes increases to support implant stability and osseointegration.

Another key factor is the increasing prevalence of oral diseases, including dental caries and periodontal conditions. These issues often lead to bone loss, necessitating grafting procedures. Moreover, the expansion of dental clinics and improved access to advanced dental care technologies are supporting market growth.

The growing popularity of minimally invasive dental procedures and improved success rates of grafting techniques are also encouraging patients to opt for these treatments.

Market Restraints

Despite strong growth prospects, the market faces certain challenges. The high cost of dental bone graft procedures remains a significant barrier, particularly in developing regions. Additionally, limited reimbursement policies for dental treatments in several countries restrict patient adoption.

Concerns related to biocompatibility and risk of infection, especially in allograft and xenograft materials, may also hinder market growth to some extent.

Market Segmentation

The dental bone graft substitutes market is segmented based on product type, form, and end-user.

By product type, the market includes allografts, xenografts, synthetic bone substitutes, and demineralized bone matrix (DBM). Among these, synthetic substitutes are gaining traction due to their safety and reduced risk of disease transmission.

By form, products are available as granules, putty, and others, with granules holding a significant share due to ease of application.

By end-user, the market is divided into solo practices, DSO/group practices, and others. Hospitals and advanced dental clinics dominate the segment due to better infrastructure and availability of skilled professionals.

Regional Insights

North America dominates the global dental bone graft substitutes market, accounting for 47.93% share in 2025, driven by a high number of dental implant procedures and strong presence of key players.

Europe holds the second-largest share, supported by increasing R&D investments and technological advancements in dental biomaterials.

The Asia Pacific region is expected to witness significant growth during the forecast period due to rising dental awareness, growing healthcare expenditure, and increasing geriatric population in countries such as China, Japan, and India.

Meanwhile, Latin America and the Middle East & Africa are experiencing gradual growth due to improving healthcare infrastructure and rising medical tourism.

Competitive Landscape & Key Players

The global market is partially consolidated, with several leading companies holding significant shares. Key players are focusing on product innovation, mergers, acquisitions, and geographic expansion to strengthen their market position.

Key Players:

• ZimVie Inc.

• Medtronic Plc

• Geistlich Pharma AG

• DENTSPLY SIRONA Inc.

• Straumann Holding AG

• Zimmer Biomet Holdings Inc.

• BioHorizons Inc.

• Botiss Biomaterials GmbH

• RTI Surgical Inc.

Among these, ZimVie Inc., Medtronic, and Geistlich Pharma AG account for a substantial portion of the global market share due to their strong product portfolios and global presence.

Industry Developments

Strategic initiatives such as acquisitions and partnerships are shaping the competitive landscape. For instance, companies are increasingly acquiring specialized biomaterial firms to enhance their regenerative product offerings.

Continuous innovation in biocompatible and synthetic graft materials is expected to create new growth opportunities in the market.

Conclusion

The dental bone graft substitutes market is poised for steady growth, supported by increasing dental implant procedures, rising oral health awareness, and advancements in biomaterials. While cost-related challenges and reimbursement limitations persist, ongoing innovations and expanding healthcare access are expected to drive long-term market expansion.